Surgical options for the management of ischemic cardiomyopathy

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Opinion statement: Novel surgical alternatives and the refinement of conventional surgical therapies for the treatment of ischemic cardiomyopathy are in constant evolution. Current approaches involve the determined application of the appropriateness criteria for CABG surgery, the extension of mitral valve repair to complex patients with ischemic cardiomyopathy, finding appropriate patients who might benefit from surgical ventricular reconstruction, and surgical attempts to regenerate lost or damaged myocardium with transplanted stem cells. The refinement of surgical techniques and the medical optimization of candidates for surgery remain a cornerstone of management for patients with complex heart disease like ischemic cardiomyopathy. The horizon is bright for patients suffering from this condition and concentrated research efforts by groups such as the NHLBI-sponsored Cardiothoracic Surgery Network will have a major impact on the future of patients with heart disease.

Original languageEnglish (US)
Pages (from-to)518-532
Number of pages15
JournalCurrent Treatment Options in Cardiovascular Medicine
Volume15
Issue number5
DOIs
StatePublished - Oct 2013

Fingerprint

Cardiomyopathies
National Heart, Lung, and Blood Institute (U.S.)
Mitral Valve
Myocardial Ischemia
Heart Diseases
Myocardium
Stem Cells
Therapeutics
Research

Keywords

  • Cardiac stem cells
  • Coronary artery bypass grafting
  • Coronary artery disease
  • Ischemic cardiomyopathy
  • Mitral valve repair
  • Surgical ventricular reconstruction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Surgical options for the management of ischemic cardiomyopathy. / Michler, Robert E.

In: Current Treatment Options in Cardiovascular Medicine, Vol. 15, No. 5, 10.2013, p. 518-532.

Research output: Contribution to journalArticle

@article{020e99b4a1f148e0b9c66c253c6f7f08,
title = "Surgical options for the management of ischemic cardiomyopathy",
abstract = "Opinion statement: Novel surgical alternatives and the refinement of conventional surgical therapies for the treatment of ischemic cardiomyopathy are in constant evolution. Current approaches involve the determined application of the appropriateness criteria for CABG surgery, the extension of mitral valve repair to complex patients with ischemic cardiomyopathy, finding appropriate patients who might benefit from surgical ventricular reconstruction, and surgical attempts to regenerate lost or damaged myocardium with transplanted stem cells. The refinement of surgical techniques and the medical optimization of candidates for surgery remain a cornerstone of management for patients with complex heart disease like ischemic cardiomyopathy. The horizon is bright for patients suffering from this condition and concentrated research efforts by groups such as the NHLBI-sponsored Cardiothoracic Surgery Network will have a major impact on the future of patients with heart disease.",
keywords = "Cardiac stem cells, Coronary artery bypass grafting, Coronary artery disease, Ischemic cardiomyopathy, Mitral valve repair, Surgical ventricular reconstruction",
author = "Michler, {Robert E.}",
year = "2013",
month = "10",
doi = "10.1007/s11936-013-0261-6",
language = "English (US)",
volume = "15",
pages = "518--532",
journal = "Current Treatment Options in Cardiovascular Medicine",
issn = "1092-8464",
publisher = "Current Science, Inc.",
number = "5",

}

TY - JOUR

T1 - Surgical options for the management of ischemic cardiomyopathy

AU - Michler, Robert E.

PY - 2013/10

Y1 - 2013/10

N2 - Opinion statement: Novel surgical alternatives and the refinement of conventional surgical therapies for the treatment of ischemic cardiomyopathy are in constant evolution. Current approaches involve the determined application of the appropriateness criteria for CABG surgery, the extension of mitral valve repair to complex patients with ischemic cardiomyopathy, finding appropriate patients who might benefit from surgical ventricular reconstruction, and surgical attempts to regenerate lost or damaged myocardium with transplanted stem cells. The refinement of surgical techniques and the medical optimization of candidates for surgery remain a cornerstone of management for patients with complex heart disease like ischemic cardiomyopathy. The horizon is bright for patients suffering from this condition and concentrated research efforts by groups such as the NHLBI-sponsored Cardiothoracic Surgery Network will have a major impact on the future of patients with heart disease.

AB - Opinion statement: Novel surgical alternatives and the refinement of conventional surgical therapies for the treatment of ischemic cardiomyopathy are in constant evolution. Current approaches involve the determined application of the appropriateness criteria for CABG surgery, the extension of mitral valve repair to complex patients with ischemic cardiomyopathy, finding appropriate patients who might benefit from surgical ventricular reconstruction, and surgical attempts to regenerate lost or damaged myocardium with transplanted stem cells. The refinement of surgical techniques and the medical optimization of candidates for surgery remain a cornerstone of management for patients with complex heart disease like ischemic cardiomyopathy. The horizon is bright for patients suffering from this condition and concentrated research efforts by groups such as the NHLBI-sponsored Cardiothoracic Surgery Network will have a major impact on the future of patients with heart disease.

KW - Cardiac stem cells

KW - Coronary artery bypass grafting

KW - Coronary artery disease

KW - Ischemic cardiomyopathy

KW - Mitral valve repair

KW - Surgical ventricular reconstruction

UR - http://www.scopus.com/inward/record.url?scp=84885950283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885950283&partnerID=8YFLogxK

U2 - 10.1007/s11936-013-0261-6

DO - 10.1007/s11936-013-0261-6

M3 - Article

VL - 15

SP - 518

EP - 532

JO - Current Treatment Options in Cardiovascular Medicine

JF - Current Treatment Options in Cardiovascular Medicine

SN - 1092-8464

IS - 5

ER -